ATE271883T1 - In ovo impfung gegen die newcastle-krankheit - Google Patents

In ovo impfung gegen die newcastle-krankheit

Info

Publication number
ATE271883T1
ATE271883T1 AT97953833T AT97953833T ATE271883T1 AT E271883 T1 ATE271883 T1 AT E271883T1 AT 97953833 T AT97953833 T AT 97953833T AT 97953833 T AT97953833 T AT 97953833T AT E271883 T1 ATE271883 T1 AT E271883T1
Authority
AT
Austria
Prior art keywords
newcastle disease
vaccination against
ovo vaccination
against newcastle
ovo
Prior art date
Application number
AT97953833T
Other languages
English (en)
Inventor
Frans Gerrit Davelaar
Original Assignee
Dimminaco Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dimminaco Ag filed Critical Dimminaco Ag
Application granted granted Critical
Publication of ATE271883T1 publication Critical patent/ATE271883T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
    • A61K39/17—Newcastle disease virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18111—Avulavirus, e.g. Newcastle disease virus
    • C12N2760/18134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Pulmonology (AREA)
  • Zoology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT97953833T 1996-12-17 1997-12-16 In ovo impfung gegen die newcastle-krankheit ATE271883T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP96203572A EP0848956A1 (de) 1996-12-17 1996-12-17 In ovo Impfung gegen die Newcastle-Krankheit
PCT/EP1997/007066 WO1998026800A1 (en) 1996-12-17 1997-12-16 In ovo vaccination against newcastle disease

Publications (1)

Publication Number Publication Date
ATE271883T1 true ATE271883T1 (de) 2004-08-15

Family

ID=8224711

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97953833T ATE271883T1 (de) 1996-12-17 1997-12-16 In ovo impfung gegen die newcastle-krankheit

Country Status (17)

Country Link
US (1) US6348197B1 (de)
EP (2) EP0848956A1 (de)
JP (1) JP2001506253A (de)
KR (1) KR100540856B1 (de)
CN (1) CN1146443C (de)
AR (1) AR010794A1 (de)
AT (1) ATE271883T1 (de)
AU (1) AU5758798A (de)
BR (1) BR9713582A (de)
CA (1) CA2273074C (de)
DE (1) DE69730040T2 (de)
DK (1) DK0938335T3 (de)
ES (1) ES2224294T3 (de)
PT (1) PT938335E (de)
TW (1) TW537896B (de)
WO (1) WO1998026800A1 (de)
ZA (1) ZA9711333B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2312626A1 (en) 1999-07-27 2001-01-27 Akzo Nobel N.V. A recombinant newcastle disease virus as an embryo vaccine
EP1074614B1 (de) * 1999-07-27 2004-07-07 Akzo Nobel N.V. Rekombinantes Newcastle-Krankheitsvirus zur in ovo Impfung
AR031405A1 (es) 2000-11-21 2003-09-24 Wyeth Corp Metodos y vacunas para conferir proteccion in ovo contra la rinotraqueitis del pavo
DE60114420T2 (de) 2001-10-04 2006-07-13 Centrum Voor Onderzoek In Diergeneeskunde En Agrochemie Abgeschwächter Mutantenstamm eines Virus der Newcastle-Krankheit für eine in Ovo Impfung und dessen Benutzung
AU2003243307B2 (en) * 2002-06-21 2010-04-01 Wellstat Biologics Corporation Administration of therapeutic viruses
TW200502402A (en) * 2002-12-06 2005-01-16 Wyeth Corp Escape mutants of newcastle disease virus as marker vaccines
WO2004113518A1 (en) * 2003-06-20 2004-12-29 Microbix Biosystems Inc. Improvements in virus production
HUE027091T2 (en) * 2006-03-30 2016-08-29 Zoetis Services Llc Procedures and preparations for vaccination of poultry
FR2921387B1 (fr) * 2007-09-26 2012-04-20 Sanofi Pasteur Procede de production du virus de la grippe
CN102559607B (zh) * 2012-01-04 2013-03-27 扬州大学 新城疫病毒高粘膜免疫水平弱毒疫苗株ndv/lx及反向遗传构建系统

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4458630A (en) 1982-06-22 1984-07-10 The United States Of America As Represented By The Secretary Of Agriculture Disease control in avian species by embryonal vaccination
DE68918649T2 (de) * 1988-07-18 1995-03-23 Duphar Int Res Lebende Newcastle-Krankheit-Virus-Vakzine.
US5427791A (en) 1992-08-05 1995-06-27 Regents Of The University Of Minnesota Embryonal vaccine against Newcastle disease

Also Published As

Publication number Publication date
CA2273074A1 (en) 1998-06-25
ZA9711333B (en) 1999-06-17
ES2224294T3 (es) 2005-03-01
JP2001506253A (ja) 2001-05-15
WO1998026800A1 (en) 1998-06-25
CA2273074C (en) 2008-04-29
CN1146443C (zh) 2004-04-21
CN1240360A (zh) 2000-01-05
HK1022273A1 (en) 2000-08-04
EP0938335A1 (de) 1999-09-01
DE69730040D1 (de) 2004-09-02
PT938335E (pt) 2004-11-30
EP0938335B1 (de) 2004-07-28
DE69730040T2 (de) 2004-12-30
AR010794A1 (es) 2000-07-12
DK0938335T3 (da) 2004-11-29
EP0848956A1 (de) 1998-06-24
BR9713582A (pt) 2000-04-04
TW537896B (en) 2003-06-21
KR20000069501A (ko) 2000-11-25
KR100540856B1 (ko) 2006-01-12
AU5758798A (en) 1998-07-15
US6348197B1 (en) 2002-02-19

Similar Documents

Publication Publication Date Title
ATE202484T1 (de) In ovo impfung gegen coccidiose
DE69734778D1 (de) Polynukleotid-impfstoffformulierung gegen pferdekrankheiten
NO20003303L (no) Vaksine
NO991524D0 (no) Vaksiner
ID20399A (id) Vaksin influensa
NO996133D0 (no) Olje-i-vann-vaksinesammensetninger
NO20006191D0 (no) Vaksine
ATE200029T1 (de) In ovo impfung gegen coccidiose
ATE271883T1 (de) In ovo impfung gegen die newcastle-krankheit
DK0956042T3 (da) Mykosevaccine
DE69629457D1 (de) Impfstoff in gelform
EP0967993A4 (de) Anti-kokaine vakzine
NO20005599L (no) Vaksine
EE9400227A (et) Loomade trihhofüütia vastane vaktsiin
KR970060699U (ko) 치주질환 보조치료용 의자
NO975301A (no) Innluftstenger
NO963946D0 (no) Fisketrapp
FIU970369U0 (fi) Lemmikkieläinarkku
IT1291083B1 (it) Macchina per la raccolta delle deiezioni negli allevamenti avicoli
NO995158L (no) TÕrn
ITTV940059V0 (it) Macchina per vaccinazioni avicole
ES1040037Y (es) Cojin natural termo-terapeutico frio-calor
DK0914417T3 (da) Human DNase II
NO985475D0 (no) Kunstig gjeller
FR2747456B1 (fr) Appareil a ferrer la biere

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0938335

Country of ref document: EP

REN Ceased due to non-payment of the annual fee